Eczema cream study halted after just 3 volunteers

NCT ID NCT07146971

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small study tested an over-the-counter cream for atopic dermatitis (eczema) in just 3 people. Researchers looked at skin bacteria, hydration, and barrier function to see if the cream helped. The study was terminated early, so results are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

OTC cosmetic cream formulation

What this could lead to

If it works, this could point toward a better understanding of how OTC creams affect skin microbiome and symptoms in atopic dermatitis.

What could go wrong

This was a tiny Phase 1 study with only 3 participants and was terminated early. Results may not be reliable or generalizable. The cream is not approved for treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sequential Skin

    New York, New York, 10013, United States